SCHEMBL1627401

SCHEMBL1627401

O=Cc1cccc2c1C(=O)NC2=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.48
PARP1 P09874 5/20 0.45
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 2/20 0.45
GAA P10253 1/20 0.45
HPGD P15428 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CASP3 P42574 4/20 0.42
CASP7 P55210 2/20 0.42
CASP2 P42575 1/20 0.42
CASP6 P55212 1/20 0.42
CASP8 Q14790 1/20 0.42
MEN1 O00255 2/20 0.41
THRB P10828 2/20 0.41
BLM P54132 2/20 0.41
KMT2A Q03164 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
LMNA P02545 1/20 0.41
ERN1 O75460 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31229225 1.00 GSK3B (0.48) GSK3BPARP1KDM4EALDH1A1GAA
SCHEMBL579203 0.82 GSK3B (0.46) GSK3BPARP1KDM4EALDH1A1GAA
SCHEMBL626418 0.82 GSK3B (0.46) GSK3BPARP1KDM4EALDH1A1GAA
Iodide SCHEMBL2495412 0.81 GSK3B (0.45) GSK3BPARP1KDM4EALDH1A1GAA
SCHEMBL8577337 0.79 KDM4E (0.45) GSK3BPARP1KDM4EALDH1A1GAA
SCHEMBL16754925 0.78 GSK3B (0.62) GSK3BPARP1KDM4EALDH1A1GAA
SCHEMBL28735098 0.77 GSK3B (0.41) GSK3BPARP1KDM4EALDH1A1GAA
SCHEMBL7693227 0.75 KDM4E (0.42) GSK3BPARP1KDM4EALDH1A1GAA
SCHEMBL7552794 0.75 KDM4E (0.42) GSK3BPARP1KDM4EALDH1A1GAA
Acrylic Acid SCHEMBL11605192 0.74 KDM4E (0.44) GSK3BPARP1KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8562922-B2 Picolylamine resins LANXESS DEUTSCHLAND GMBH (US) 2013-10-22 US disclosed
US-8563622-B2 Picolylamine resins LANXESS DEUTSCHLAND GMBH (DE) 2013-10-22 US disclosed
WO-2010131054-A9 REDOX DRUG DERIVATIVES BRADFORD PHARMA LIMITED (GB) 2011-05-12 WO disclosed
US-20110091365-A1 PICOLYLAMINE RESINS LANXESS DEUTSCHLAND GMBH (DE) 2011-04-21 US disclosed
US-20110086935-A1 PICOLYLAMINE RESINS LANXESS DEUTSCHLAND GMBH (DE) 2011-04-14 US disclosed
US-4952608-A CONTROLLING PH TO IMPROVE STABILITY BAYER AKTIENGESELLSCHAFT (DE) 1990-08-28 US disclosed